C.
Live / Applied — Fifth extension granted (statement of use) (as of 23 Apr 2025)
What this means for you
Not registered yet, but its 07 Mar 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97298868
- Mark type
- Design + words
- Filed
- 07 Mar 2022
- Published for opposition
- 24 Jan 2023
- Attorney of record
- B. Brett Heavner
Goods and services
- Class 005 — Pharmaceuticals: human pharmaceuticals for the treatment of pulmonary diseases, pulmonary conditions, bronchoconstrictive diseases, bronchoconstrictive conditions; infectious diseases, neurological diseases and conditions, neuromuscular diseases and conditions, musculoskeletal disorders, and diseases and conditions associated with skeletal muscle dysfunction, skeletal muscle wasting, skeletal muscle atrophy, skeletal muscle weakness, metabolic diseases and disorders, diabetes, hypertension, vascular diseases, and diseases and conditions associated with dysfunction of non-muscle myosin
Owner
- Cytokinetics, Incorporated, South San Francisco, CA, US
- Cytokinetics, Incorporated, South San Francisco, CA, US
Prosecution history
- 24 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Apr 2025 — SOU EXTENSION 5 GRANTED
- 01 Apr 2025 — SOU EXTENSION 5 FILED
- 01 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 18 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Mar 2025 — SOU EXTENSION 4 GRANTED
- 09 Jan 2025 — SOU EXTENSION 4 FILED
- 09 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 22 Nov 2024 — CORRECTED NOA E-MAILED
- 22 Nov 2024 — DIVISIONAL PROCESSING COMPLETE
- 20 Aug 2024 — DIVISIONAL REQUEST RECEIVED
- 24 Oct 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 20 Aug 2024 — TEAS REQUEST TO DIVIDE RECEIVED
- 20 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Aug 2024 — SOU EXTENSION 3 GRANTED